“…A recent randomized clinical trial reported that among patients with complex CAD (LM or 3-vessel disease), the low (0-22) SYNTAX score group showed no significantly different adverse cardiac and cerebrovascular event (MACCE) rates between treatment groups (CABG vs. PCI). In contrast, patients with intermediate (23)(24)(25)(26)(27)(28)(29)(30)(31)(32) or high SYNTAX scores (≥33) had significantly higher MACCE rates with PCI than with CABG [16]. Based on the overall results of this trial at 5 years, CABG should remain the standard of care for patients with a high or intermediate SYNTAX score, while PCI is an acceptable alternative in patients with lesscomplex disease [16].…”